Vijaya Diagnostic [VIJAYA] vs Strides Pharma [STAR] Detailed Stock Comparison
Vijaya Diagnostic
NSE
Loading...
Strides Pharma
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vijaya Diagnostic wins in 8 metrics, Strides Pharma wins in 12 metrics, with 0 ties. Strides Pharma appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Vijaya Diagnostic | Strides Pharma | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 68.97 | 22.79 | Strides Pharma |
| Price-to-Book Ratio | 12.99 | 3.05 | Strides Pharma |
| Debt-to-Equity Ratio | 39.99 | 72.67 | Vijaya Diagnostic |
| PEG Ratio | 3.01 | 0.55 | Strides Pharma |
| EV/EBITDA | 35.59 | 12.20 | Strides Pharma |
| Profit Margin (TTM) | 21.04% | 7.38% | Vijaya Diagnostic |
| Operating Margin (TTM) | 27.99% | 15.11% | Vijaya Diagnostic |
| EBITDA Margin (TTM) | 27.99% | 15.11% | Vijaya Diagnostic |
| Return on Equity | 17.90% | 138.93% | Strides Pharma |
| Return on Assets (TTM) | 11.23% | 59.41% | Strides Pharma |
| Free Cash Flow (TTM) | $1.29B | $4.42B | Strides Pharma |
| Dividend Yield | 0.30% | 0.74% | Strides Pharma |
| 1-Year Return | 10.43% | -35.55% | Vijaya Diagnostic |
| Price-to-Sales Ratio (TTM) | 14.55 | 1.68 | Strides Pharma |
| Enterprise Value | $103.78B | $96.44B | Vijaya Diagnostic |
| EV/Revenue Ratio | 14.55 | 2.08 | Strides Pharma |
| Gross Profit Margin (TTM) | 88.61% | 60.32% | Vijaya Diagnostic |
| Revenue per Share (TTM) | $70 | $503 | Strides Pharma |
| Earnings per Share (Diluted) | $14.63 | $37.08 | Strides Pharma |
| Beta (Stock Volatility) | -0.10 | 0.57 | Vijaya Diagnostic |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Vijaya Diagnostic vs Strides Pharma Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic | 1.29% | -1.30% | -9.99% | 5.97% | 10.05% | -5.17% |
| Strides Pharma | 2.21% | -0.21% | -9.52% | 10.55% | 39.42% | 22.63% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic | 10.43% | 163.27% | 60.73% | 60.73% | 60.73% | 60.73% |
| Strides Pharma | -35.55% | 163.52% | 44.37% | -19.09% | 121.81% | 204.96% |
Performance & Financial Health Analysis: Vijaya Diagnostic vs Strides Pharma
| Metric | VIJAYA | STAR |
|---|---|---|
| Market Information | ||
| Market Cap | ₹103.79B | ₹77.89B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 191,896 | 319,089 |
| 90 Day Avg. Volume | 445,588 | 445,415 |
| Last Close | ₹1,007.80 | ₹863.70 |
| 52 Week Range | ₹740.00 - ₹1,275.00 | ₹513.05 - ₹1,675.00 |
| % from 52W High | -20.96% | -48.44% |
| All-Time High | ₹1,275.00 (Jan 13, 2025) | ₹1,675.00 (Oct 14, 2024) |
| % from All-Time High | -20.96% | -48.44% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.20% | 0.03% |
| Quarterly Earnings Growth | 0.22% | 0.42% |
| Financial Health | ||
| Profit Margin (TTM) | 0.21% | 0.07% |
| Operating Margin (TTM) | 0.28% | 0.15% |
| Return on Equity (TTM) | 0.18% | 1.39% |
| Debt to Equity (MRQ) | 39.99 | 72.67 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹77.65 | ₹276.88 |
| Cash per Share (MRQ) | ₹22.90 | ₹21.55 |
| Operating Cash Flow (TTM) | ₹2.04B | ₹36.02B |
| Levered Free Cash Flow (TTM) | ₹1.43B | ₹35.93B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.30% | 0.74% |
| Last 12-Month Dividend | ₹3.00 | ₹6.50 |
Valuation & Enterprise Metrics Analysis: Vijaya Diagnostic vs Strides Pharma
| Metric | VIJAYA | STAR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 68.97 | 22.79 |
| Forward P/E | 50.65 | 13.13 |
| PEG Ratio | 3.01 | 0.55 |
| Price to Sales (TTM) | 14.55 | 1.68 |
| Price to Book (MRQ) | 12.99 | 3.05 |
| Market Capitalization | ||
| Market Capitalization | ₹103.79B | ₹77.89B |
| Enterprise Value | ₹103.78B | ₹96.44B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14.55 | 2.08 |
| Enterprise to EBITDA | 35.59 | 12.20 |
| Risk & Other Metrics | ||
| Beta | -0.10 | 0.57 |
| Book Value per Share (MRQ) | ₹77.65 | ₹276.88 |
Financial Statements Comparison: Vijaya Diagnostic vs Strides Pharma
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | VIJAYA | STAR |
|---|---|---|
| Revenue/Sales | ₹1.88B | ₹11.20B |
| Cost of Goods Sold | ₹214.13M | ₹4.44B |
| Gross Profit | ₹1.67B | ₹6.75B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹526.44M | ₹1.69B |
| EBITDA | ₹805.82M | ₹2.27B |
| Pre-Tax Income | ₹522.07M | ₹1.22B |
| Income Tax | ₹136.18M | ₹164.50M |
| Net Income (Profit) | ₹385.89M | ₹1.06B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | VIJAYA | STAR |
|---|---|---|
| Cash & Equivalents | ₹128.01M | ₹1.13B |
| Total Current Assets | ₹3.07B | ₹31.02B |
| Total Current Liabilities | ₹1.63B | ₹25.92B |
| Long-Term Debt | ₹2.96B | ₹6.23B |
| Total Shareholders Equity | ₹7.99B | ₹25.86B |
| Retained Earnings | N/A | ₹4.59B |
| Property, Plant & Equipment | ₹7.24B | ₹8.81B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | VIJAYA | STAR |
|---|---|---|
| Operating Cash Flow | ₹282.28M | N/A |
| Capital Expenditures | ₹-648.48M | N/A |
| Free Cash Flow | ₹-321.75M | N/A |
| Debt Repayment | ₹-2.72M | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | VIJAYA | STAR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 191,896 | 319,089 |
| Average Daily Volume (90 Day) | 445,588 | 445,415 |
| Shares Outstanding | 102.64M | 92.16M |
| Float Shares | 47.92M | 56.69M |
| % Held by Insiders | 0.53% | 0.33% |
| % Held by Institutions | 0.43% | 0.25% |
Dividend Analysis & Yield Comparison: Vijaya Diagnostic vs Strides Pharma
| Metric | VIJAYA | STAR |
|---|---|---|
| Last 12-Month Dividend | ₹3.00 | ₹6.50 |
| Last 12-Month Dividend Yield | 0.30% | 0.74% |
| 3-Year Avg Annual Dividend | ₹1.67 | ₹2.67 |
| 3-Year Avg Dividend Yield | 0.19% | 0.32% |
| 3-Year Total Dividends | ₹5.00 | ₹8.00 |
| Ex-Dividend Date | Aug 29, 2025 | Jul 22, 2025 |